Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Expert review of neurotherapeutics - 1 Nov 2009

Rezai-Zadeh Kavon, Gate David, Szekely Christine A, Town Terrence

Abstract excerpt

Alzheimer's disease (AD) is the leading cause of dementia in elderly populations throughout the world and its incidence is on the rise. Current clinical diagnosis of AD requires intensive examination that includes neuropsychological testing and costly brain imaging techniques, and a definitive di...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Biomarkers
Share to Leukocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 19903022
DOI: 10.1586/ern.09.118
PMCID: PMC2828773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19903022-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?PMID 19903022Read ↗

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Methodology for Discovery of Alzheimer's Disease Blood-Based BiomarkersSemantic proximity Read ↗

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer′s DiseaseSemantic proximity Read ↗

Cellular transcriptional alterations of peripheral blood in Alzheimer’s diseaseSemantic proximity Read ↗

Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s DiseaseSemantic proximity Read ↗

The role of monocytes and macrophages in the progression of Alzheimer’s diseaseSemantic proximity Read ↗

Adaptive immune changes associate with clinical progression of Alzheimer’s diseaseSemantic proximity Read ↗

Single-cell multi-omic profiling allows the dissection of peripheral immune phenotypes in Alzheimer’s Disease progressionSemantic proximity Read ↗

Tracking the progression of Alzheimer’s disease with peripheral blood monocytesSemantic proximity Read ↗

Innovative Biomarkers for Alzheimer’s Disease: Focus on the Hidden Disease BiomarkersSemantic proximity Read ↗

Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.